Robust and low-cost ELISA based on IgG-Fc tagged recombinant proteins to screen for anti-SARS-CoV-2 antibodies

The development of new diagnostic assays become a priority for managing COVID-19. To this aim, we presented here an in-house ELISA based on the production of two major recombinant and high-quality antigens from SARS-CoV-2. Full-length N and S-RBD fragment proteins fused to mouse IgG2a-Fc were produc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol Methods
Main Authors: Frumence, Etienne, Lebeau, Grégorie, Viranaicken, Wildriss, Dobi, Anthony, Vagner, Damien, Lalarizo Rakoto, Mahary, Sandenon Seteyen, Anne-Laure, Giry, Claude, Septembre-Malaterre, Axelle, Raffray, Loïc, Gasque, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2021
Assuntos:
Technical Note
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8152238/
https://ncbi.nlm.nih.gov/pubmed/34051226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jim.2021.113082
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados